MYR Pharmaceuticals Announces Presentation of Final Results of the MYR203 Study of bulevirtide (Myrcludex) at the International Liver Congress (ILC) 2019 in Vienna. – PRNewswire

MYR Pharmaceuticals Announces Presentation of Final Results of the MYR203 Study of bulevirtide (Myrcludex) at the International Liver Congress (ILC) 2019 in Vienna.  PRNewswire

BURGWEDEL, Germany, April 4, 2019 /PRNewswire/ — MYR Pharmaceuticals today announced that the final results of the MYR203 study of bulevirtide …

Original published: 2019-04-04 15:28:00 Read the full Vienna News here


Some local news is curated - Original might have been posted at a different date/ time! Click the source link for details.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.